Quazomotide
Quazomotide is a WT1-derived class II peptide epitope (RSDELVRHHNMHQRNMTKL) that induces peptide-specific CD4+ T-cell responses. It functions as both an immunotherapeutic agent for active vaccination and an antineoplastic agent, with research applications in targeting WT1-positive cancers in vitro and in vivo.
Product Specifications
Molecular Weight
2402.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H7651-05A 50 µg
Hsc70-interacting Protein (ST13, Hip, Progesterone Receptor-associated p48 Protein, Protein FAM10A1, Putative Tumor Suppressor ST13, Renal Carcinoma Antigen NY-REN-33, Suppression of Tumorigenicity 13 Protein, FAM10A1, HIP, SNC6) discontinued
Sign In for Pricing
View Details 
MBS1074839-01 0.02 mg (E-Coli)
Recombinant Enterobacteria phage lambda Protein ea10 (ea10)
Sign In for Pricing
View Details MBS1074839-02 0.1 mg (E-Coli)
Recombinant Enterobacteria phage lambda Protein ea10 (ea10)
Sign In for Pricing
View Details MBS1074839-03 0.02 mg (Yeast)
Recombinant Enterobacteria phage lambda Protein ea10 (ea10)
Sign In for Pricing
View Details MBS1074839-04 0.1 mg (Yeast)
Recombinant Enterobacteria phage lambda Protein ea10 (ea10)
Sign In for Pricing
View Details